Azor Biotek

Azor Biotek is a private Canadian biotechnology company developing RNA-targeted small-molecule therapeutics using an AI-guided drug discovery platform. The company focuses on designing novel compounds against stabilized RNA/protein biological complexes rather than naked RNA structures, and combines computational chemistry with phenotypic screening in zebrafish and other translational models. Azor describes its platform as target- and disease-agnostic, with applications across oncology, neuroscience, psychiatry, and other areas of unmet need. Publicly available materials indicate a preclinical-stage pipeline with an emphasis on microRNA-targeted therapeutics and early-stage partnering or service work in RNA target selection, drug design, and early development.